Related Experiment Video

Updated: Aug 10, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

Neonatal osteomyelitis

L Fox, K Sprunt

    Pediatrics
    |October 1, 1978
    PubMed

    Insights

    Neonatal osteomyelitis in infants is often diagnosed early and can affect multiple sites. A shift in causative bacteria from Staphylococcus aureus to group B beta-hemolytic streptococci occurred between 1951-1976.

    Area of Science:

    • Pediatrics
    • Infectious Diseases
    • Orthopedic Surgery

    Background:

    • Neonatal osteomyelitis presents unique challenges in diagnosis and treatment.
    • Understanding shifts in causative pathogens is crucial for effective management.

    Purpose of the Study:

    • To evaluate conservative (nonsurgical) therapy for neonatal osteomyelitis.
    • To document changes in the primary etiologic agents causing osteomyelitis in newborns.

    Main Methods:

    • Retrospective review of 45 infant cases of osteomyelitis admitted between 1951-1976.
    • Analysis of disease characteristics, causative agents, treatment, and outcomes.

    Main Results:

    • Most cases (73%) were diagnosed within the first two weeks of life.
    • Distinctive infection patterns included multiple foci, facial bones, and contiguous joint involvement.
    • A significant shift in etiology was observed: Staphylococcus aureus predominated before 1965, followed by group B beta-hemolytic streptococci from 1965-1976.

    Conclusions:

    • Conservative therapy is a viable option for most infants with neonatal osteomyelitis.
    • The changing landscape of etiologic agents necessitates ongoing surveillance and adaptive treatment strategies.

    More Related Videos

    A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis05:39

    A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

    Published on: November 30, 2021

    Neonatal Mouse Bone Marrow Isolation and Preparation of Bone Marrow-Derived Macrophages06:53

    Neonatal Mouse Bone Marrow Isolation and Preparation of Bone Marrow-Derived Macrophages

    Published on: May 24, 2024

    Related Concept Videos

    Bone Formation by Intramembranous Ossification01:29

    Bone Formation by Intramembranous Ossification

    Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
    The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...
    Development of the Oral Microbiota01:28

    Development of the Oral Microbiota

    The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
    Bacterial Meningitis01:24

    Bacterial Meningitis

    Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Bacterial Meningitis I: Introduction01:22

    Bacterial Meningitis I: Introduction

    Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
    Bacterial Meningitis II: Pathophysiology01:26

    Bacterial Meningitis II: Pathophysiology

    Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...